Skip to main content

POMDOCTOR Ltd

corporate_fare Company Profile

POMDOCTOR Ltd

POM·NASDAQ·Trade & Services·CIK 0001877971

PomDoctor is a Cayman Islands holding company that conducts its operations primarily through contractual arrangements with Qilekang Digital Health, a Variable Interest Entity (VIE), and its subsidiaries based in China. Investors in PomDoctor's American Depositary Shares (ADSs) do not directly hold equity interests in the VIE. The company's corporate structure involves contractual arrangements with Qilekang Digital Health and its shareholders, which have not been tested in any of the PRC courts. There are uncertainties regarding the interpretation and application of current and future PRC laws, regulations, and rules concerning these contractual arrangements. If the PRC government determines these arrangements do not comply with restrictions on direct foreign investment in relevant industries, or if PRC laws, regulations, and rules or their interpretation change, PomDoctor could face penalties, be forced to give up its interests in the VIE, or lose its rights under the contractual arrangements. PomDoctor and its investors face uncertainty about potential future actions by the PRC government that could affect the enforceability of these contractual arrangements.

POMDOCTOR Ltd (NASDAQ:POM) is a publicly traded company in the Trade & Services sector. Wiseek monitors POM SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • POMDOCTOR Plans 1-for-18 Reverse ADS Split to Address Nasdaq Delisting Risk
  • POMDOCTOR Reports Widened FY2025 Net Loss of $18.7M, Operating Cash Burn of $21.2M; IPO Proceeds Consumed
  • Auditor Expresses Substantial Doubt on Going Concern; Nasdaq Delisting Warning Issued Amid Worsening Financials
  • POMDOCTOR Ltd Changes Auditor to HYYH CPA. LLC Amidst Prior Material Weaknesses
  • POMDOCTOR Expands Medical Insurance Integration Across Major Chinese Cities

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
¥399.91M CNY
Net Income
-¥130.93M CNY
Diluted EPS
-¥21.96 CNY
Op. Cash Flow
-¥148.48M CNY
Free Cash Flow
-¥149.49M CNY
Gross Profit
¥52.28M CNY
Operating Income
-¥118.63M CNY
Cash & Equivalents
¥9.58M CNY
Total Debt
¥134.82M CNY
Debt / Equity
-0.30×
Net Margin
-32.7%
Shares Outstanding
9.68M sh
Source: 20-F · filed 2026-05-14 · accession 0001213900-26-056576

Insider Transactions

POM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with P →
$0.0977 -0.00% today
52-week range · as of 2026-05-28 $0.0649 – $6.43
Market cap
$14.12M
Volume
673.5K (0.0× avg)
3-mo avg 13.8M
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed POM - Latest Insights

POM
May 28, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
POMDOCTOR Plans 1-for-18 Reverse ADS Split to Address Nasdaq Delisting Risk
Price at Filing: $0.110
Real-time Price: $0.0977 info
Change: -$0.0123 (-11%) info
Market Cap: $14.118M info
Sentiment: Negative
View Wiseek Article
POM
May 14, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
9
POMDOCTOR Reports Widened FY2025 Net Loss of $18.7M, Operating Cash Burn of $21.2M; IPO Proceeds Consumed
Price at Filing: $0.1125
Real-time Price: $0.0977 info
Change: -$0.0148 (-13%) info
Market Cap: $14.118M info
Sentiment: Negative
View Wiseek Article
POM
May 14, 2026, 4:01 PM EDT
Filing Type: 20-F
Importance Score:
9
Auditor Expresses Substantial Doubt on Going Concern; Nasdaq Delisting Warning Issued Amid Worsening Financials
Price at Filing: $0.1204
Real-time Price: $0.0977 info
Change: -$0.0227 (-19%) info
Market Cap: $14.118M info
Sentiment: Negative
View Wiseek Article
POM
Apr 20, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
7
POMDOCTOR Ltd Changes Auditor to HYYH CPA. LLC Amidst Prior Material Weaknesses
Price at Filing: $0.4095
Real-time Price: $0.0977 info
Change: -$0.3118 (-76%) info
Market Cap: $14.118M info
Sentiment: Neutral
View Wiseek Article
POM
Feb 04, 2026, 8:11 AM EST
Filing Type: 6-K
Importance Score:
9
POMDOCTOR Expands Medical Insurance Integration Across Major Chinese Cities
Price at Filing: $0.2411
Real-time Price: $0.0977 info
Change: -$0.1434 (-59%) info
Market Cap: $14.118M info
Sentiment: Positive
View Wiseek Article
POM
Feb 02, 2026, 6:29 AM EST
Filing Type: 6-K
Importance Score:
9
POMDOCTOR Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price
Price at Filing: $0.2464
Real-time Price: $0.0977 info
Change: -$0.1487 (-60%) info
Market Cap: $14.118M info
Sentiment: Negative
View Wiseek Article
POM
Jan 16, 2026, 9:08 AM EST
Filing Type: 6-K
Importance Score:
7
POMDOCTOR Strengthens Strategic Pharma Partnerships to Drive Internet Hospital Growth
Price at Filing: $0.301459
Real-time Price: $0.0977 info
Change: -$0.203759 (-68%) info
Market Cap: $14.118M info
Sentiment: Positive
View Wiseek Article